Skip to main content
. 2011 Jun 30;33(13):1625–1634. doi: 10.1093/eurheartj/ehr193

Figure 2.

Figure 2

Leucocyte activation at baseline and following nicotine administration in humans with normal and reduced myeloperoxidase activity. (A) Matrix metalloproteinase-9 plasma levels before and after stimulation with nicotine. (B) Myeloperoxidase plasma levels before and following nicotine administration are shown. Data are displayed for the 15 subjects with reduced myeloperoxidase expression and/or activity (MPOlow) subjects and for the 30 matched controls.